Get started
Author

Sarette T. Tilton

Observed names: S T Tilton, S. Tilton, S.T. Tilton, Sarette T Tilton, Sarette Tilton, Tilton, Sarette T.
OpenAlex ID: A5037478338
Competencies and Feedback on Internal Medicine Residents’ End-of-Rotation Assessments Over Time: Qualitative and Quantitative Analyses
2019 · Ara Tekian, Yoon Soo Park, et al. · Academic Medicine · 30
Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis
2024 · Jonathan M. Spergel, Mirna Chehade, et al. · The American Journal of Gastroenterology · 17
What do quantitative ratings and qualitative comments tell us about general surgery residents’ progress toward independent practice? Evidence from a 5-year longitudinal cohort
2018 · Ara Tekian, Martin Borhani, et al. · The American Journal of Surgery · 16
Identification of barriers to safe opioid prescribing in primary care: a qualitative analysis of field notes collected through academic detailing
2020 · Christopher D Saffore, Sarette T Tilton, et al. · British Journal of General Practice · 14
PDF
Validation of the novel Eosinophilic Esophagitis Impact Questionnaire
2023 · Eilish McCann, Mirna Chehade, et al. · Journal of Patient-Reported Outcomes · 10
PDF
Development of a measure of prescriber satisfaction with academic detailing: the PSAD
2022 · Andrea L Monteiro, Mary Smart, et al. · Drugs in Context · 8
PDF
Burden of eosinophilic esophagitis in adult and adolescent patients: results from a real-world analysis
2025 · Alain M Schoepfer, Stevie Olsen, et al. · Diseases of the Esophagus · 6
PDF
Economic Burden and Health Care Resource Utilization of Patients With Eosinophilic Esophagitis in the United States
2025 · Mirna Chehade, Andrew J. Epstein, et al. · Journal of Clinical Gastroenterology · 5
Psychometric evaluation of the Dysphagia Symptom Questionnaire for adults and adolescents with eosinophilic esophagitis
2024 · Eilish McCann, Kathryn A. Peterson, et al. · Journal of Allergy and Clinical Immunology Global · 4
A Real-World Study of Cumulative Steroid Burden Among Patients With Eosinophilic Esophagitis in the United States
2025 · Mirna Chehade, David A. Katzka, et al. · Clinical Gastroenterology and Hepatology · 3
PDF
Validation of the Novel Pediatric Eosinophilic Esophagitis Sign/Symptom Questionnaire-Caregiver Version in EoE KIDS
2026 · Mirna Chehade, Eilish McCann, et al. · The Journal of Allergy and Clinical Immunology In Practice · 1
Dupilumab Improves Multiple Aspects of Dysphagia Symptoms in a Randomized Trial of Eosinophilic Esophagitis
2025 · Evan S. Dellon, Mirna Chehade, et al. · Clinical Gastroenterology and Hepatology · 1
PDF
Validation of the novel Eosinophilic Esophagitis Symptom Questionnaire
2025 · Eilish McCann, Mirna Chehade, et al. · Journal of Allergy and Clinical Immunology Global · 1
Disease burden, diagnosis pathways and treatment patterns in patients with eosinophilic esophagitis: a real-world study
2025 · Christopher Ma, Ulrike von Arm, et al. · European Journal of Gastroenterology & Hepatology · 1
A206 Dupilumab Treatment Reduces the Frequency of Dysphagia Days and Actions to Relieve Dysphagia in Patients With Eosinophilic Esophagitis (eoe): Results From the Phase 3 Liberty Eoe Treet Study
2024 · E Dellon, I Hirano, et al. · Journal of the Canadian Association of Gastroenterology · 1
PDF
S393 Health Care Resource Utilization and Costs Among Eosinophilic Esophagitis Patients in the United States
2022 · Mirna Chehade, Andrew J. Epstein, et al. · The American Journal of Gastroenterology · 1
Dupilumab improves clinical outcome assessments in children with eosinophilic esophagitis in a randomized phase 3 study
2026 · Mirna Chehade, Jonathan M. Spergel, et al. · BMC Gastroenterology
Additional file 1 of Dupilumab improves clinical outcome assessments in children with eosinophilic esophagitis in a randomized phase 3 study
2026 · Mirna Chehade, Jonathan M. Spergel, et al. · Figshare
904 Symptom Burden, Adaptive Behaviors, and Health-related Quality of Life in Patients With Eosinophilic Esophagitis: a Cross-sectional Survey in the United States
2026 · Mirna Chehade, Kathryn A. Peterson, et al. · Gastroenterology
904 Symptom Burden, Adaptive Behaviors, and Health-related Quality of Life in Patients With Eosinophilic Esophagitis: a Cross-sectional Survey in the United States
2026 · Mirna Chehade, Kathryn A. Peterson, et al. · Gastrointestinal Endoscopy
Dupilumab improves symptoms and quality of life in patients with eosinophilic esophagitis: a plain language summary
2026 · Mary Jo Strobel, Jonathan M. Spergel, et al. · Immunotherapy
PDF
Dupilumab Leads to Sustained Treatment Response Up to 52 Weeks in Dysphagia and Odynophagia Associated with Eosinophilic Esophagitis in Adults and Adolescents: Post-Hoc Analysis of the LIBERTY EoE TREET Study
2026 · Evan Dellon, Antonella Cianferoni, et al. · Journal of Allergy and Clinical Immunology
Poster Session II - A195 DUPILUMAB IMPROVES DYSPHAGIA, ODYNOPHAGIA, CHEST PAIN, AND HEARTBURN IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS UP TO 52 WEEKS: POST HOC ANALYSIS OF THE LIBERTY EOE TREET STUDY
2026 · E Dellon, M Gupta, et al. · Journal of the Canadian Association of Gastroenterology
S821 Real-World Study of Biopsy Practices During Food Impactions in the Emergency Department: Multi-State GI Practice
2025 · Walker D. Redd, Evan S. Dellon, et al. · The American Journal of Gastroenterology
S912 Dupilumab Treatment Patterns for Eosinophilic Esophagitis in the United States: A Real-World Study
2025 · Kathryn A. Peterson, Rohan C. Parikh, et al. · The American Journal of Gastroenterology
Works count: 40
Citation count: 119
H-index: 6
I10-index: 5
Year
Topic
Type